Dr. Reddy's set to acquire Nimbus Health
The acquisition will allow Dr. Reddy's to build on Nimbus Health's strengths and introduce medical cannabis-based medicines as a promising treatment option for patients
The acquisition will allow Dr. Reddy's to build on Nimbus Health's strengths and introduce medical cannabis-based medicines as a promising treatment option for patients
Mental health issues are a cause for concern and in a conservative society like India. Thomas C Thottathil spoke to Krishna Veer Singh, Co-Founder and CEO of Lissun, a young start-up working in the space of mental health
It will enable the company to branch out to new geographies and strengthen its presence in South Africa
A National Tele Mental Health Programme is being launched to address mental health issues. We spoke to healthcare industry leaders who shared their outlook
Pegfilgrastim is indicated to reduce the duration of neutropenia and the incidence of febrile neutropenia in patients receiving chemotherapy
The acquisition of myPOLS Biotec complements Medix Biochemica’s leading portfolio of IVD raw materials and expands its reagent offerings for molecular diagnostics
Sun Pharmaceutical Industries has reported consolidated financial results for the period ended December 31, 2021
ICICI Direct analysis of Dr Reddy’s Q3FY22 results
Vabysmo is the only injectable eye medicine approved simultaneously in the US for wet AMD and DME, with flexible dosing regimens based on patient need
ABDM is a digital framework that will connect patients, doctors and other healthcare stakeholders nationwide to facilitate safe and secure movement of health information
Subscribe To Our Newsletter & Stay Updated